Source: Annual Congress 2004 - PG8 - Defining clinical asthma phenotypes: implications for therapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. F. Chung (London, United Kingdom). Steroid resistant asthma. Annual Congress 2004 - PG8 - Defining clinical asthma phenotypes: implications for therapy

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of therapeutic resistant and steroid resistant bronchial asthma in children and adolescents Source: Eur Respir J 2005; 26: Suppl. 49, 681s Year: 2005 Adherence to steroid treatment in asthma Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Steroid resistant CD28nullCD8+NKT-like pro-inflammatory cells in COPD Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Pharmacogenetics of inhaled corticosteroid response in adults with asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Inhaled antibiotic therapy in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 The efficacy of steroid with pentoxifylline in steroid resistant sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006 Fungal sensitisation in children with severe therapy resistant asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012 Steroid therapy as an environmental factor in asthmatic patients: Drifting towards COPD Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Higher doses of inhaled steroid are associated with bacterial bronchitis in children with severe therapy resistant asthma (STRA) Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets Year: 2016 Difficult/therapy - resistant asthma Source: Guideline 1999 Year: 1999 Cyclosporin A is effective for the patients with interstitial pneumonia resistant to steroid therapy Source: Eur Respir J 2004; 24: Suppl. 48, 507s Year: 2004 Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose Year: 2018 Systemic steroid use in children with allergic (IgE-mediated) asthma receiving omalizumab Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Bronchial asthma as neurogenic inflammatory and paroxysmal disease – efficacy of antiepileptic drug diphenine in asthma therapy Source: Eur Respir J 2006; 28: Suppl. 50, 316s Year: 2006 Inhaled steroids in the treatment of newly detected asthma Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004 Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease? Source: Eur Respir J 2006; 28: Suppl. 50, 204s Year: 2006 Dehydroepiandrosterone in the treatment of steroid resistant asthma: Whether synthetic nanoform can replace the natural hormone? Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Characteristics of paediatric difficult asthma and systemic corticosteroid responsiveness Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008